Singular Genomics Systems, Inc. announced the launch of its Max Read™ Kits for single cell applications on the company's G4 Sequencing Platform at the Advances in Genome Biology and Technology 23rd General Meeting, taking place February 6–9, 2023, in Hollywood, Florida. The Max Read Kits boost the potential output of the G4 to a market-leading 3.2 billion reads per run on a benchtop system for single cell sequencing. The kits, specifically designed to match the format of popular 10x Genomics assays, enable users the flexibility to sequence 4, 8, 12, or 16 samples per run, each in its own lane.

The company plans for the sequencing kits to be priced at $1 per million reads and provide 800 million reads per flow cell with 80–90% Q30 quality. Singular Genomics also increased the quality specifications for the G4 Sequencing Platform, including the F2 and F3 flow cells, to 80–90% Q30 quality, and raised the throughput range of the F2 and F3 flow cells to up to 250 million and up to 450 million reads, respectively. The company will provide additional details on Max Read Kits and F3 Flow Cell Kit data during the AGBT meeting, including a presentation by Eli Glezer, Ph.D., Co-Founder and Chief Scientific Officer of Singular Genomics, on February 8, 2023, at 4:30 p.m. Eastern Time.